Risk Stratification and Treatment Decisions in Essential Thrombocythemia

This chapter examines how to assess risk in older patients with essential thrombocythemia by evaluating factors like biological age, lifestyle, and genetic mutations. It underscores the need for personalized treatment approaches, balancing options from low-dose aspirin to intensive therapies while noting the limitations of existing controlled studies.